E-Paper
Sign In
Cipla to sell weight-loss drug Mounjaro's active ingredient in India
The Indian drugmaker has signed an agreement with Eli Lilly to sell tirzepatide in the country
- PUBLISHED: Thu 23 Oct 2025, 2:36 PM
Indian drugmaker Cipla signed an agreement with Eli Lilly to sell tirzepatide, the active ingredient in the US company's blockbuster weight-loss drug Mounjaro, in India, the companies said on Thursday.